Tumor microRNA signatures associate with stage II/III melanoma patient outcomes. Wiggins JM, Zhang Q, Zhang Y, Vand-Rajabpour F, et al. Clin Cancer Res 2025 Oct 20. doi: 10.1158/1078-0432.CCR-24-3785.

Read + Share

Amedeo Smart

Independent Medical Education

Wiggins JM, Zhang Q, Zhang Y, Vand-Rajabpour F, et al. Tumor microRNA signatures associate with stage II/III melanoma patient outcomes. Clin Cancer Res 2025 Oct 20. doi: 10.1158/1078-0432.CCR-24-3785.
PMID: 41114662